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The genome‑wide promoter interactome is primarily maintained and regulated by architectural 
proteins such as CTCF and cohesin. However, some studies suggest a role for non‑coding RNAs 
(ncRNAs) in this process. We aimed to characterise the regulatory role of RNA‑mediated promoter 
interactions in the control of gene expression. We integrated genome‑wide datasets of RNA‑
chromatin and promoter‑genome interactions in human embryonic stem cells (hESCs) to identify 
putative RNA‑mediated promoter interactions. We discovered that CTCF sites were enriched in RNA‑
PIRs (promoter interacting regions co‑localising with RNA‑chromatin interaction sites) and genes 
interacting with RNA‑PIRs containing CTCF sites showed higher expression levels. One of the long 
noncoding RNAs (lncRNAs) expressed in hESCs, Syntaxin 18-Antisense 1 (STX18-AS1), appeared to 
be involved in an insulating promoter interaction with the neighbouring gene, MSX1. By knocking 
down STX18-AS1, the MSX1 promoter‑PIR interaction was intensified and the target gene (MSX1) 
expression was down‑regulated. Conversely, reduced MSX1 promoter‑PIR interactions, resulting from 
CRISPR‑Cas9 deletion of the PIR, increased the expression of MSX1. We conclude that STX18-AS1 
RNA antagonised local CTCF‑mediated insulating promoter interactions to augment gene expression. 
Such down‑regulation of the insulating promoter interactions by this novel mechanism may explain 
the higher expression of genes interacting with RNA‑PIRs linked to CTCF sites.
Gene regulation involves the formation of three dimensional (3D) chromosomal interactions to bring distal 
genomic regulatory elements to spatial proximity of gene  promoters1,2. The occurrence of these long-range 
chromosomal interactions is not only mediated by protein factors that are key players in maintaining genome 
architecture such as CCCTC binding factor (CTCF), Yin Yang 1 (YY1) and the Mediator and cohesin complexes, 
but also the widespread non-coding RNAs (ncRNAs) transcribed in the  genome3. For example, Thymocyte Differ-
entiation factor (ThymoD) ncRNA activates cohesin-dependent looping to juxtapose the enhancer and promoter 
of B cell lymphoma/leukaemia 11b (Bcl11b) gene into a single loop domain for T cell fate specifying  expression4. 
Functional intergenic repeating RNA element (Firre), a long intergenic noncoding RNA (lincRNA) localises across 
a 5 Mb domain around its transcription site and this domain interacts with several trans-chromosomal  loci5. 
Deletion of the Firre locus leads to the loss of the trans-chromosomal interactions, suggesting a role for Firre 
lincRNA in 3D chromosomal  organisation5.
Although the mechanism by which ncRNAs facilitate long-range chromosomal interactions is largely 
unknown, it has been hypothesised that this function is made possible by their flexible modular domains that 
bind proteins, DNAs and other RNAs and bring these regulatory components to close  proximity6. Architectural 
proteins such as the Mediator complex, CTCF and YY1 have been shown to associate with  RNAs7–10. Depletion 
of Mediator’s subunits or activating ncRNAs reduces the chromatin looping between the activating ncRNAs 
and their target  genes7, whilst mutations at CTCF’s RNA interaction sites cause the loss of chromatin  loops10. 
In the case of cohesin, the positioning of the complex requires active transcription in the mouse  genome11 and 
displacement of it depends on the ‘read-through’ transcription (extending past the 3′ ends of genes) in the host 
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cell during the influenza A infection to decompact the  locus12. This mechanism is an example of how the tran-
scription itself, but not the resulting RNAs, can affect 3D genome  organisation3.
In this study, we aimed to characterise the regulatory role of RNA-mediated promoter interactions in the 
control of gene expression. Recently, genome-wide and targeted methods have been devised to map RNA–DNA 
contacts in the genome, providing the experimental capability to understand the role of RNAs in chromosomal 
 interactions13–17. Promoter-genome and RNA-genome mapping have been performed on human embryonic stem 
cells (hESCs) and their differentiated cells to understand the maintenance of pluripotency and the differentia-
tion  process15,18,19. Here we integrate promoter capture HiC (PCHiC) and mapping RNA-genome interactions 
(MARGI) datasets of H9 hESCs to identify and investigate putative RNA-mediated promoter interactions 15,19, 
and elucidate the role of a functionally important long noncoding RNA (lncRNA), Syntaxin 18-Antisense 1 
(STX18-AS1), in one of the promoter interactions of hESCs. SNPs in the region of the STX18-AS1 gene have 
been associated with atrial septal defects of the heart in multiple  studies20–23.
Results
CTCF and YY1 binding sites are enriched in RNA‑PIRs. We found that of the 53,563 unique pro-
moter interaction regions (PIRs) in the genome of H9 hESCs previously  reported19, 20,984 of them overlapped 
with genomic regions that are interacting with RNAs as identified through proximity MARGI (pxMARGI)15 
(Fig. 1A). We hypothesised that RNAs play a role in the promoter-genome interactions, therefore we first investi-
gated whether PIRs interacting with RNAs (RNA-PIRs) have enrichments for architectural protein binding such 
as CTCF and YY1. While CTCF is responsible for large chromosomal interactions to provide a 3D architecture 
for genes and their regulatory elements, more specific promoter-enhancer interactions are mediated by  YY124.
Figure 1.  Enrichment of CTCF or YY1 binding sites in promoter interacting regions interacting with RNAs 
(RNA-PIRs). (A) Numbers and percentages of PIRs in human embryonic stem cells (hESCs) interacting with 
RNAs and containing binding sites of CTCF or YY1. (B) Odds Ratios (ORs) and p-values of CTCF or YY1 site 
enrichment were estimated from binary logistic regression analyses including PIR size as a covariate. ***p-values 
obtained from binary logistic regression analyses were lower than the p-values obtained from the same analyses 
performed with 1000 randomised CTCF or YY1 site sets (permutation P < 1.0x10-3).
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We obtained CTCF and YY1 binding sites of H1 hESCs from the Encyclopaedia of DNA Ele-
ments (ENCODE)25,26 and intersected them with the PIRs (Supplementary Table 1). 20.6% of RNA-PIRs con-
tained CTCF binding sites, whereas only 9.8% of PIRs that are not interacting with RNAs (nonRNA-PIRs) had 
CTCF binding sites (odds ratio [OR] = 1.78; 95% CI = 1.69–1.88; P = 4.98 ×  10−100). Similarly, 8.5% of RNA-PIRs 
contained YY1 binding sites, while 4.1% of nonRNA-PIRs contained these sites (OR = 1.67; 95% CI = 1.55–1.81; 
P = 1.02 ×  10–37) (Fig. 1). The PIR size, which correlates with the probability of overlap, was included as a covariate 
in the binary logistic regression (Fig. 1B). We generated null distributions for the p-values of the binary logistic 
regression analyses by subjecting 1000 randomly generated genomic interval sets matching those in the CTCF 
or YY1 binding site sets to the same analyses. None of the p-values produced using randomised sets was lower 
than the actual p-values, hence the p-values of the binary logistic regression analyses were significantly lower 
than their null distributions (permutation P < 1.0 ×  10–3).
PIRs are HindIII fragments and not the biological demarcations for the chromatin interacting regions. There-
fore the intersection of PIRs and CTCF sites only indicates their physical proximity for the convenience of bio-
informatic investigations, but not the actual sites where specific CTCF-mediated promoter interactions occur.
Genes interacting with RNA‑PIRs containing CTCF or YY1 binding sites have higher expression 
levels than those interacting with nonRNA‑PIRs containing CTCF or YY1 binding sites. To 
understand if the expression of genes interacting with RNA-PIRs containing CTCF or YY1 sites are regulated 
differentially compared to those interacting with nonRNA-PIRs containing CTCF or YY1 sites, we obtained pre-
viously reported transcriptomic data of H9  hESCs19 and calculated average expression levels of genes interacting 
with the two categories of PIRs: (1) RNA-PIRs with CTCF or YY1 binding sites, or (2) nonRNA-PIRs with CTCF 
or YY1 binding sites (Fig. 2).
Between the categories, genes interacting with RNA-PIRs containing CTCF or YY1 sites appeared to have 
significantly higher expression levels (P = 1.74 ×  10–5 for CTCF sites and P = 5.89 ×  10–3 for YY1 sites), while genes 
interacting with nonRNA-PIRs with CTCF or YY1 sites had lower expression levels (Fig. 2). From these results, 
RNAs seemed to have up-regulated genes in the presence of CTCF or YY1, through long-range promoter-genome 
interactions in the nucleus.
The co‑regulation of RNAs and CTCF at PIRs plays an important role in biological processes 
in hESCs. Given that RNA-PIRs were enriched for more CTCF or YY1 sites and genes interacting with 
RNA-PIRs containing CTCF or YY1 sites exhibited higher expression levels, we hypothesised that the genes 
interacting with a PIR where both RNAs and CTCF/YY1 co-localised are the genes responsible for the biologi-
cal functions of hESCs. We looked into the ontology of genes interacting with the RNA-PIRs containing CTCF 
or YY1 sites using g:Profiler27 (Supplementary Table 2). We compared the unique list of genes interacting with 
RNA-PIRs containing CTCF (3456 genes) or YY1 (2309 genes) sites with the unique list of genes interacting with 
nonRNA-PIRs containing CTCF (2060 genes) or YY1 (1321 genes) sites (Fig. 3).
g:Profiler returned the biological processes of genes that were significantly overrepresented in the unique gene 
lists (adjusted P < 0.01). The genes interacting with RNA-PIRs containing CTCF sites were significantly enriched 
in a wide range of development and cellular regulation processes (Supplementary Table 2). However, genes 
interacting with nonRNA-PIRs containing CTCF sites showed much fewer significant biological processes and 
no overlap when compared to genes interacting with RNA-PIRs containing CTCF sites, as only an “animal 
organ development” process was returned (Fig. 3). This suggests that the genes interacting with RNA-PIRs 
Figure 2.  Average expression levels (mean Transcript Per Million [TPM]) of genes interacting with two 
categories of promoter interacting regions (PIRs): RNA-PIRs with CTCF or YY1 binding sites, and nonRNA-
PIRs with CTCF or YY1 binding sites. Pairwise p-values were obtained from Mann–Whitney tests.
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were involved in a wider range of the biological functions happening in hESCs than the genes interacting with 
nonRNA-PIRs.
Conversely, genes interacting with RNA-PIRs containing YY1 sites and genes interacting with nonRNA-
PIRs containing YY1 sites belonged to similar biological processes. The two lists of genes shared 13 processes 
in development and cellular regulation (Fig. 3). Therefore, the results suggest that RNAs play a more important 
role in their co-regulation with CTCF than YY1. RNAs and CTCF, but not CTCF alone, regulate more genes 
involved in a broader range of biological functions in hESCs, whereas YY1, with or without RNAs, regulates 
genes belonging to a similar range of ontologies.
STX18-AS1 RNA represses an insulating promoter‑PIR interaction of the neighbouring MSX1 
gene. We further investigated the RNA-CTCF co-regulation in promoter interactions by experimentally 
manipulating a promoter interaction between the promoter of Msh Homeobox 1 (MSX1), a transcription factor 
gene that plays a role in vertebrate  embryogenesis28, and an RNA-PIR that is interacting with Syntaxin 18-Anti-
sense 1 (STX18-AS1), an lncRNA in hESCs. STX18-AS1 gene contains genetic variants associated with atrial 
septal defects of the heart in genome-wide association studies (GWAS)20–23. As an RNA-PIR, We hypothesised 
that MSX1 promoter-PIR interaction is insulating the expression of MSX1 due to the association of RNA-RIRs 
with CTCF/YY1 sites as seen in Fig. 1B. In Fig. 4A, it is apparent that hESC CTCF sites are abundant between the 
PIR of MSX1 and the promoter of MSX1, but YY1 sites are very sparse in the region, suggesting that CTCF is the 
main factor that mediates this chromatin interaction. We also hypothesised that STX18-AS1 RNA upregulates 
MSX1 expression, as the RNA presence in CTCF-mediated promoter interactions led to higher expression levels 
of the target gene of promoter interactions as seen in Fig. 2.
Firstly, we knocked down the expression of STX18-AS1 RNA using paired guide RNA (gRNA) CRISPR-
Cas9  technology29 to delete the first and second exons of STX18-AS1 gene (Fig. 4A,B). We then checked the 
effect of STX18-AS1 knock-down on the MSX1 gene by quantifying MSX1 gene expression using qPCR and 
MSX1 promoter-PIR interaction using 3C-qPCR. MSX1 expression was down-regulated but MSX1 promoter-
PIR interaction was up-regulated when STX18-AS1 RNA was knocked down (Fig. 4B). These findings support 
the hypotheses that the MSX1 promoter-PIR interaction acts as a CTCF-mediated interaction with an insulating 
effect on MSX1 expression. Our results would be consistent with STX18-AS1 RNA antagonising this interaction 
to upregulate the expression of MSX1. We confirmed this result by knocking down STX18-AS1 using Antisense 
Locked Nucleic Acid (LNA) GapmeR  technology30 targeting the second exon of STX18-AS1 gene. MSX1 was 
similarly down-regulated as a consequence (Fig. 4C)—the confirmation with GapmeR demonstrating that no 
additional regulatory element in the region removed by CRISPR-Cas9 was influencing the result of the CRISPR-
Cas9 experiment. Thus, STX18-AS1 RNA acted as a positive regulator for MSX1 expression regardless of the 
knock-down technology used.
In order to verify the insulating effect of MSX1 promoter-PIR interaction, we down-regulated the interaction 
by deleting part of the PIR that does not overlap with the STX18-AS1 gene using paired gRNA CRISPR-Cas9 
(Fig. 4A,D). The PIR deletion did not affect the expression of STX18-AS1 RNA but reduced the amount of MSX1 
promoter-PIR interaction (Fig. 4D). In this case, the expression of MSX1 was up-regulated, providing additional 
evidence that the MSX1 promoter-PIR interaction is indeed a CTCF-mediated interaction with an insulating 
effect on MSX1 expression.
When designing the gRNA constructs for deleting STX18-AS1 gene and the PIR interacting with MSX1, 
regions rich in MSX1-targeting expression quantitative trait loci (eQTLs) were avoided (Fig. 4A). Therefore 
the experimental effects on MSX1 caused by the deletions were aptly explained by the manipulations of STX18-
AS1 expression and MSX1 promoter-PIR interaction, while no known cis-regulatory elements of MSX1 were 
Figure 3.  Numbers of biological processes (g:Profiler) that were significantly overrepresented (adjusted 
p < 0.01) in unique lists of genes interacting with RNA-PIRs or nonRNA-PIRs containing CTCF or YY1 sites.
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disrupted. All the CRISPR-Cas9 and GapmeR manipulations in this study did not significantly affect the expres-
sion of the upstream STX18 gene or pluripotent marker genes SOX2 and OCT4 (Fig. 4E).
Figure 4.  Chromosomal interaction between MSX1 promoter and its promoter interacting region (PIR) 
mediated by a noncoding RNA, STX18-AS1. (A) Genomic locations of MSX1 and STX18-AS1 genes, CTCF and 
YY1 binding sites in H1 human embryonic stem cells (hESCs), GTEx expression quantitative trait loci (eQTLs) 
targeting MSX1 gene, guide RNA (gRNA) sequences for deleting the first two exons of STX18-AS1 gene and 
part of MSX1 PIR using CRISPR-Cas9, and PIRs associated with RNAs (the MSX1 promoter-PIR interaction 
was represented by an arc line). (B) Effects of STX18-AS1 down-regulation by deleting part of STX18-AS1 gene 
using CRISPR-Cas9 on MSX1 expression and MSX1 promoter-PIR interaction. (C) Effects of STX18-AS1 down-
regulation by a specific GapmeR on STX18-AS1 and MSX1 expression levels. (D) Effects of downregulated 
MSX1 promoter-PIR interaction by deleting part of MSX1 RNA-PIR using CRISPR-Cas9 on expression levels of 
STX18-AS1 and MSX1. E) Effects of STX18-AS1 and MSX1 RNA-PIR CRISPR-Cas9 deletions, and STX18-AS1 
GapmeR on expression levels of STX18, SOX2 and OCT4.*P < 0.05; **P < 0.01. All p-values were obtained from T 
tests with Bonferroni correction if multiple comparisons apply.
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Discussion
In this study we identified putative genome-wide RNA-mediated promoter-genome interactions in hESCs by 
integrating PCHiC and MARGI datasets and dissecting the role of an exemplar RNA in such an interaction. We 
provide evidence that RNAs co-regulate promoter interactions with CTCF. Firstly, binding sites of CTCF were 
more enriched in RNA-PIRs than nonRNA-PIRs. Secondly, genes interacting with RNA-PIRs containing CTCF 
sites had higher expression levels in the cells. Thirdly, genes interacting with RNA-PIRs containing CTCF sites, 
but not nonRNA-PIRs with CTCF sites, were overrepresented in a broad range of biological processes such 
as development and cellular regulation. On the other hand, genes interacting with PIRs containing YY1 sites 
belonged to a similar range of biological processes, with or without RNAs. Taking all the findings together, they 
suggest that RNAs and CTCF work together in maintaining and regulating promoter interactions.
By knocking down the RNA (STX18-AS1) of one of the putative RNA-mediated promoter-genome interac-
tions (MSX1 promoter-PIR interaction), the promoter interaction was intensified and the expression of the target 
gene (MSX1) was down-regulated. This suggests that the promoter interaction is repressive or insulating. The 
majority of promoter-genome interactions are maintained by architectural proteins such as CTCF and cohesin; 
indeed most promoter-genome interactions are lost when CTCF and cohesin are  degraded31. Given the abun-
dance of CTCF sites in the genomic region and CTCF being the major insulating factor to mediate promoter 
interactions, they suggest that the RNA (STX18-AS1) represses a CTCF-mediated insulating interaction with 
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MSX1 promoter-PIR interaction through deleting part of the PIR, indicating that the promoter interaction is 
both necessary and sufficient to regulate MSX1 expression. Given the high expression levels shown by the genes 
interacting with RNA-PIRs containing CTCF sites, it supports the conclusion that the CTCF-mediated insulating 
promoter interactions can be suppressed by RNAs, just like the MSX1 promoter-PIR interaction that insulates 
the MSX1 expression is being suppressed by STX18-AS1 RNA in hESCs.
Materials and methods
hESC maintenance. H9 (WA09) hESC line was a publicly available cell line obtained from WiCell, cultured 
in monolayers and maintained according to WiCell Feeder-Independent Pluripotent Stem Cell Protocols (SOP-
SH-002) using mTeSR1 medium (STEMCELL Technologies).
CRISPR‑Cas9 and lentiviral transduction. gRNA sequences (provided in Supplementary Table 3) used 
to delete STX18-AS1 gene and MSX1 PIR in H9 hESC were cloned into pLentiCRISPRv2 (Addgene; plasmid 
52961) according to published paired gRNA  design29 using human U6 promoter for both gRNA sequences. The 
cloned pLentiCRISPRv2 and second-generation packaging plasmids psPAX2 (Addgene; plasmid 12260) and 
pMD2.G (Addgene; plasmid 12259) were co-transfected into HEK293T cells (cultured in DMEM (Gibco) sup-
plemented with 10% FBS and 1 × penicillin–streptomycin at 37  ˚C and 5%  CO2) in the proportion of 4:3:2 using 
Lipofectamine 2000 (Invitrogen) for lentivirus production. Lentivirus-containing media were collected 48  h 
after transfection, centrifuged to remove cell debris and 0.45 µm filtered before transducing H9 hESC monolay-
ers (40–60% confluency) in the presence of 33% v/v mTESR1 media (STEMCELL Technologies), 8 µg/ml poly-
brene (Millipore) and 10 µM ROCK inhibitor. 24 h post-transduction, second transduction was repeated with 
fresh lentivirus-containing media. 24 h after the second transduction, the transduced H9 hESC were selected in 
0.8 µg/ml puromycin media for 48 h. The strength of puromycin was less than the standard for better hESC sur-
vival, therefore the 48-h puromycin selection step was repeated every time the cells were passaged. The deletions 
of STX18-AS1 gene and MSX1 PIR were confirmed by PCR and Sanger sequencing (primers and product sizes 
are provided in Supplementary Table 3; results are in Supplementary Figs. 1 and 2). All CRISPR-Cas9 experi-
ments were controlled by cells transduced with an empty pLentiCRISPRv2 plasmid.
Antisense LNA GapmeR experiment. The GapmeR targeting STX18-AS1/LOC100507266 lncRNA 
(NR_037888.1) was designed using EXIQON LNA GapmeR On-Line Design Tool (http:// www. exiqon. com/ 
gapme rs). Both STX18-AS1 and negative GapmeRs (details provided in Supplementary Table  3) were sup-
plied by Qiagen/Exiqon at HPLC purification grade. GapmeRs were transfected to cells using Lipofectamine 
RNAiMAX according to the manufacture’s instruction (Invitrogen). Briefly for each 12-well of cells at ~ 60% 
confluency (1 ml of medium), 10 µl Lipofectamine RNAiMAX and 50 pmol GapmeR were added to cells and 
incubated at 37 °C for 24 h. The same procedure was repeated after 24 h and cells were incubated for another 
24 h before the collection.
3C library preparation. 3C libraries were prepared according to a published  protocol32. In summary, 
20 million hESCs were fixed by 2% formaldehyde (Agar Scientific; R1026) for 10 min at room temperature, 
quenched by cold 0.125 M glycine (5 min at room temperature followed by 15 min on ice), flash-frozen in liq-
uid nitrogen and stored at − 80 °C. The cross-linked cells were lysed and the chromatin digested with HindIII 
at 37 °C for overnight. Then in-nucleus ligation was carried out at 16 °C for 4–6 h before reverse-crosslinking 
was achieved by overnight treatment of proteinase K at 65 °C. The DNA was purified by RNaseA treatment for 
60 min at 37 °C, sequential phenol and phenol–chloroform extractions, and ethanol-precipitation at − 20 °C for 
overnight. On the following day, two further phenol–chloroform extractions and a second overnight precipita-
tion were performed to further purify the DNA. The promoter interaction junctions between two HindIII frag-
ments were confirmed by PCR and Sanger sequencing (primers and band sizes are provided in Supplementary 
Table 3; results for MSX1 and ERCC Excision Repair 3 (ERCC3) interactions (positive/internal control) are in 
Supplementary Figs. 3 and 4).
Polymerase chain reaction (PCR). Genomic DNA (gDNA) was extracted from cells using PureLink 
Genomic DNA Mini Kit (Invitrogen) and total RNA  using Trizol (Invitrogen). First-strand complementary 
DNA (cDNA) was synthesised from DNase (Promega) treated total RNA using M-MLV Reverse Transcriptase 
(Promega) and both random hexamer and oligo(dT) primers (Promega). PCR was performed using OneTaq 
2 × Master Mix (New England BioLabs) and the primers provided in Supplementary Table 3. For quantitative 
PCR (qPCR), gene expression was quantified by TaqMan assays (Applied Biosystems; assay details are provided 
in Supplementary Table 3) using a ViiA7 qPCR system (Applied Biosystems). For each qPCR reaction, ~ 40 ng 
cDNA templates were used with TaqMan Gene Expression Master Mix (Applied Biosystems; stock concentra-
tion 2 ×) and the TaqMan assays (Applied Biosystems; stock concentration 20 ×). Promoter interactions in 3C 
libraries were quantified using SYBR Green PCR Master Mix (Applied Biosystems) and primers (information 
provided in Supplementary Table 3) in a ViiA7 qPCR system (Applied Biosystems). Three replicates were done 
for each qPCR reaction with the programme of 95 °C for 10 min, 40 × (95 °C for 15 s, 60 °C for 1 min). Importin 
8 (IPO8) was included as the internal control for expression quantification, while ERCC3 interaction was used as 
the positive/internal/positive control for interaction  quantification33.
Data processing and statistical analyses. RNA-chromatin interactions were obtained from http:// syste 
msbio. ucsd. edu/ margi/ (pxMARGI)15. To compare to the promoter-PIR interactions, coordinates in hg38 were 
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converted to hg19 using UCSC liftover function (https:// genome. ucsc. edu/). RNA or DNA regions with ambigu-
ous mapping between genome builds or that mapped to ‘unlocalized’ or ‘unplaced’ regions were removed from 
further analyses. This resulted in 734,970 unique RNA–DNA interactions and 601,055 unique RNA-interacting 
DNA regions. Unique PIRs from H9  hESCs19 excluding interchromosomal interacting regions (53,563) were 
then overlapped with these RNA–interacting DNA regions. A total of 20,984 of these PIRs were found to overlap 
RNA-interacting DNA regions, whereas the remaining 32,579 PIRs had no evidence of RNA interaction from 
these data.
Promoter-PIR interactions with evidence of accompanying RNA interaction, and those without RNA interac-
tion, were assessed for overlap with CTCF and YY1 sites using the ENCODE CTCF and YY1 sites from H1 hESC 
cells (Consortium, 2012; Consortium et al., 2020). CTCF or YY1 sites overlapping PIRs (RNA or non-RNA) 
were counted using a consensus of all 5 ENCODE CTCF and 2 ENCODE YY1 sets (downloadable from https:// 
genome. ucsc. edu/; “Uniform TFBS” and “ENCODE 3 TFBS” tracks). For greater confidence in the overlaps, PIR 
and CTCF/YY1 overlaps were only counted if all datasets agreed (i.e. all 5 in the case of CTCF overlap and 2 in 
the case of YY1 overlap). Any degree of intersection between the PIRs and these high-confidence feature sets 
was included. We performed binary logistic regression, using PIR length as a covariate, to determine statistical 
significance of the difference between PIRs with/without RNA and CTCF/YY1 intersection. For negative con-
trols, we generated consensus genomic intervals from the 5 CTCF and 2 YY1 datasets respectively. These were 
randomly shuffled within the genome using Bedtools (v2.27.1; https:// bedto ols. readt hedocs. io/ en/ latest/). 1000 
randomly generated interval sets were then assessed for their intersection with PIRs through the same statistical 
analysis as the actual data.
Gene promoters interacting with PIRs either associated with RNAs, CTCF or YY1 sites were assessed for the 
expression levels of their respective genes in H9 hESCs. H9 hESC RNA-seq dataset was downloaded from GEO 
(gene expression omnibus) accession GSE86821 (Freire-Pritchett et al., 2017). Raw data from the two replicates 
were pooled and transcript expression values determined using Kallisto (Bray et al., 2016) and the GRCh38 rel79 
transcriptome from Ensembl (https:// www. ensem bl. org/). The mean expression values in terms of Transcripts 
Per Million (TPM) for genes identified in each overlapping PIR set (“RNA and CTCF”, “CTCF-only”, “RNA-only” 
and “neither”) were calculated and compared.
g:Profiler (https:// biit. cs. ut. ee/ gprofi ler/ gost)27 was used to identify the overrepresentations of biological pro-
cesses in gene lists. eQTLs were obtained from GTEx V8 (https:// gtexp ortal. org/ home/).
Data from qPCR were analysed using the 2^(−ΔΔCt) method as previously  described34. According to this 
method, means and standard errors are calculated from ΔCT values.
Standard statistical methods mentioned were performed with relevant R packages or other publicly available 
tools. Sample scripts and steps of this study are available on https:// github. com/ keavn eylab/ PIR- RNA- CTCF.
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